Fabio Buttari Selected Research

Fabio Buttari Research Topics

Disease

56	Multiple Sclerosis 08/2024 - 10/2009
26	Inflammation (Inflammations) 10/2023 - 02/2011
10	Relapsing-Remitting Multiple Sclerosis 10/2023 - 06/2014
8	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 05/2024 - 03/2011
8	Disease Progression 01/2022 - 03/2011
5	Neuroinflammatory Diseases 05/2024 - 01/2018
3	Alzheimer Disease (Alzheimer's Disease) 03/2023 - 02/2011
3	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2020 - 12/2013
3	Progressive Multifocal Leukoencephalopathy 01/2017 - 08/2014
3	Pain (Aches) 01/2017 - 12/2009
2	COVID-19 10/2023 - 07/2021
2	Cognitive Dysfunction 03/2023 - 02/2011
2	Nervous System Diseases (Neurological Disorders) 01/2023 - 12/2014
2	Fatigue 08/2022 - 01/2020
2	Anhedonia 01/2020 - 01/2018
2	Demyelinating Diseases (Demyelinating Disease) 01/2019 - 01/2019
2	Neuralgia (Stump Neuralgia) 01/2018 - 05/2010
2	Huntington Disease (Huntington's Disease) 01/2018 - 01/2017
2	Clinical Deterioration 06/2014 - 12/2013
1	Optic Nerve Diseases (Optic Neuropathy) 11/2023
1	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 01/2023
1	Parkinson Disease (Parkinson's Disease) 01/2023
1	Mood Disorders (Mood Disorder) 10/2022
1	Necrosis 11/2021
1	Starvation 01/2021
1	Severe combined immunodeficiency due to adenosine deaminase deficiency 01/2020
1	Obesity 01/2020
1	Neuromyelitis Optica (Devic's Disease) 11/2019
1	Bradycardia 11/2019
1	Microcephaly 01/2019
1	autosomal recessive 1 Spinocerebellar ataxia 01/2019
1	Encephalitis (Encephalitis, Rasmussen) 01/2019

Drug/Important Bio-Agent (IBA)

13	CytokinesIBA 01/2023 - 11/2014
6	Natalizumab (Tysabri)FDA Link 03/2018 - 01/2013
5	Proteins (Proteins, Gene)FDA Link 03/2023 - 02/2011
5	Fingolimod Hydrochloride (FTY720)FDA Link 12/2019 - 02/2017
4	Glutamic Acid (Glutamate)FDA Link 01/2023 - 01/2017
4	Biomarkers (Surrogate Marker)IBA 01/2022 - 02/2016
4	nitazoxanide (NTZ)FDA Link 02/2017 - 08/2014
3	COVID-19 VaccinesIBA 11/2023 - 07/2021
3	EnzymesIBA 03/2023 - 01/2019
3	MicroRNAs (MicroRNA)IBA 01/2023 - 01/2017
3	Interleukin-6 (Interleukin 6)IBA 01/2022 - 10/2019
3	Platelet-Derived Growth FactorIBA 04/2018 - 12/2013
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2018 - 03/2014
2	Retinaldehyde (Retinal)IBA 11/2023 - 01/2013
2	VaccinesIBA 10/2023 - 07/2021
2	Messenger RNA (mRNA)IBA 10/2023 - 01/2022
2	Amyloid (Amyloid Fibrils)IBA 03/2023 - 02/2011
2	D-Aspartic Acid (D Aspartate)IBA 01/2023 - 01/2020
2	Amino Acids FDA Link 01/2023 - 01/2023
2	InterleukinsIBA 08/2022 - 01/2020
2	ocrelizumabIBA 01/2022 - 07/2021
2	Cladribine FDA LinkGeneric 07/2021 - 01/2020
2	InterferonsIBA 01/2021 - 01/2017
2	Dronabinol (THC)FDA LinkGeneric 10/2020 - 12/2009
2	CannabidiolIBA 10/2020 - 12/2009
2	LipidsIBA 01/2020 - 01/2020
2	Rituximab (Mabthera)FDA Link 11/2019 - 11/2014
2	Dimethyl FumarateIBA 11/2019 - 10/2018
2	CuprizoneIBA 01/2019 - 01/2019
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 04/2018 - 06/2014
2	Therapeutic UsesIBA 01/2018 - 12/2014
2	CannabinoidsIBA 01/2018 - 03/2011
2	EndocannabinoidsIBA 01/2017 - 12/2009
2	Interferon-betaIBA 01/2017 - 01/2014
2	CB1 Cannabinoid Receptor (CB1 Receptor)IBA 12/2014 - 03/2011
2	nabiximols (Sativex)IBA 12/2009 - 10/2009
1	Interleukin-9 (Interleukin 9)IBA 05/2024
1	OsteopontinIBA 01/2023
1	Extracellular Matrix ProteinsIBA 01/2023
1	Interleukin-8 (Interleukin 8)IBA 01/2023
1	Excitatory Amino AcidsIBA 01/2023
1	Aspartic Acid (Aspartate)FDA Link 01/2023
1	Serine (L-Serine)FDA Link 01/2023
1	Interleukin-2 (IL2)IBA 10/2022
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 10/2022
1	Interleukin-10 (Interleukin 10)IBA 08/2022
1	Interleukin-1beta (Interleukin 1 beta)IBA 11/2021
1	ParvalbuminsIBA 11/2021
1	PlatinumIBA 01/2021
1	Amino Acid Transport Systems (Amino Acid Transporter)IBA 01/2021
1	EicosanoidsIBA 01/2020
1	Sphingosine-1-Phosphate ReceptorsIBA 01/2020
1	lipoxin B4IBA 01/2020
1	Adenosine DeaminaseIBA 01/2020
1	TabletsIBA 01/2020
1	NucleotidesIBA 01/2020
1	lipoxin A4IBA 01/2020
1	Acetylcholine (Acetylcholine Chloride)FDA Link 11/2019
1	AntioxidantsIBA 11/2019
1	Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA 11/2019
1	Cholinergic Agents (Cholinergics)IBA 11/2019
1	GlucocorticoidsIBA 10/2019
1	Annexin A1IBA 10/2019
1	Lysophosphatidylcholines (Lysophosphatidylcholine)IBA 01/2019

Therapy/Procedure

4	Therapeutics 08/2024 - 01/2017
3	Transcranial Magnetic Stimulation 01/2022 - 01/2017
3	Injections 01/2021 - 02/2017
1	Immunomodulation 10/2022